Grail

Why Ilumina's Stock Fell 13.5% in September
Why Ilumina's Stock Fell 13.5% in September
Motley Fool
Illumina
Grail
M&A
gene sequencing
Flag link:
Is Illumina Making an $8 Billion Blunder?
Is Illumina Making an $8 Billion Blunder?
Motley Fool
Illumina
Grail
M&A
diagnostics
investors
Flag link:
Report: Illumina in Talks to Acquire Cancer Diagnostics Startup Grail
Report: Illumina in Talks to Acquire Cancer Diagnostics Startup Grail
Motley Fool
M&A
diagnostics
cancer diagnostics
cancer
oncology
Illumina
Grail
Flag link:
Secretive, $1.6 billion liquid biopsy player Grail files IPO, revealing 2021 commercial plans
Secretive, $1.6 billion liquid biopsy player Grail files IPO, revealing 2021 commercial plans
Endpoints
Grail
liquid biopsies
IPOs
Flag link:
Medtech venture investors live up to their name
Medtech venture investors live up to their name
EP Vantage
Medtech
devices
startups
venture capital
COVID-19
pandemic
Grail
Karius
InSightec
Oxford Nanapore
Outset Medical
Reflexion Medical
Hinge Health
Flag link:
Biopharma Companies Continue to Expand, Add Jobs Despite Ongoing Pandemic
Biopharma Companies Continue to Expand, Add Jobs Despite Ongoing Pandemic
BioSpace
pharma industry
biotech
pandemic
COVID-19
hirings
AGC Biologics
Grail
Grifols
CRISPR Therapeutics
Sana Biotechnology
Point
Sanofi
Medpharm
Regeneron
Flag link:
Blood test for cancer detection company Grail rakes in $390M in latest round
Blood test for cancer detection company Grail rakes in $390M in latest round
Endpoints
diagnostics
Grail
oncology
cancer
Flag link:
Grail's Next-Gen Multi-Cancer Test Detects 50 Early-Stage Cancers with 93% Accuracy
Grail's Next-Gen Multi-Cancer Test Detects 50 Early-Stage Cancers with 93% Accuracy
BioSpace
Grail
diagnostics
oncology
cancer
Flag link:
Dana-Farber Study Confirms Accuracy of GRAIL's Blood Test for Cancer
Dana-Farber Study Confirms Accuracy of GRAIL's Blood Test for Cancer
BioSpace
diagnostics
Grail
Dana-Farber
cancer
Flag link:
Grail’s Cook Steps Down, Former Juno Executive Bishop Named CEO
Grail’s Cook Steps Down, Former Juno Executive Bishop Named CEO
BioCentury
Grail
diagnostics
Juno Therapeutics
Celgene
Flag link:
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More
Xconomy
ASCO 2019
cancer
immunotherapy
diagnostics
Veracyte
Grail
Moderna Therapeutics
Amgen
Nektar Therapeutics
Blueprint Medicines
Merck
AstraZeneca
Roche
breast cancer
Flag link:
Grail, a deep-pocketed startup, outlines its plans for a blood test to detect cancer
Grail, a deep-pocketed startup, outlines its plans for a blood test to detect cancer
Stat
Grail
diagnostics
ASCO 2019
cancer
Flag link:
Grail, the liquid biopsy startup, picks an approach for its cancer test
Grail, the liquid biopsy startup, picks an approach for its cancer test
Stat
Grail
diagnostics
liquid biopsy
cancer
clinical trials
Flag link:
Is There a Diagnostic Company to Rise From the Ashes of Theranos?
Is There a Diagnostic Company to Rise From the Ashes of Theranos?
BioSpace
diagnostics
Theranos
Guardant Health
Karius
Freenome
Apostle
Grail
liquid biopsy
Genalyte
Abbott Labs
Athelus
Flag link:
#ASCO18: A Weekend of Surprises
#ASCO18: A Weekend of Surprises
Motley Fool
ASCO 2018
Bluebird Bio
Loxo Oncology
Nektar Therapeutics
Celgene
Grail
Flag link:
Biotech Firm Grail Takes The First Steps In Its Quest For A Blood Test For Cancer
Biotech Firm Grail Takes The First Steps In Its Quest For A Blood Test For Cancer
Forbes
Grail
cancer
oncology
diagnostics
Flag link:
GRAIL Raises $300 Million in Series C to Pursue Early Cancer Detection Mission
GRAIL Raises $300 Million in Series C to Pursue Early Cancer Detection Mission
CP Wire
Grail
cancer
diagnostics
Flag link:
GRAIL Raises $300 Million in Series C to Pursue Early Cancer Detection Mission
Grail
Flag link:
He Built Google Maps. Now He'll Lead The Development Of A Blood Test For Cancer
He Built Google Maps. Now He'll Lead The Development Of A Blood Test For Cancer
Forbes
Jeff Huber
cancer
Google
Grail
diagnostics
Flag link:
Illumina Starts Cancer Blood Test Firm With Bezos, Gates Backing
Illumina Starts Cancer Blood Test Firm With Bezos, Gates Backing
Bloomberg
Illumina
Jeff Bezos
Bill Gates
diagnostics
cancer
Grail
genetic sequencing
Flag link: